Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.

摘要: Despite clinical trial evidence supporting the use of antiplatelets, angiotensin-converting enzyme inhibitors, and statins for cardiovascular risk reduction in high-risk patients, such therapies real-world outpatients prospective Vascular Protection Registry Guidelines Oriented Approach to Lipid Lowering was suboptimal (78%, 55%, 75%, respectively). The most frequent reason physicians cited nonprescription (33%) that patients were not high enough and/or current guidelines did support statin use. In conclusion, at continue be undertreated as a result combination physician underestimation (knowledge gap) barriers implementation evidence-based therapy (practice gap).